Dec 31, 2017
Erdheim-Chester Disease and the NIH Undiagnosed Disease Program were the topics of discussion at the joint LSU and Tulane University event.
Dec 31, 2017
“Erdheim-Chester disease: Characteristics & Management” is presented by Filip Janku, MD, PhD
Dec 31, 2017
Funding from ECD patients and their families and friends opens access to treatment facilities regardless of patient location.
Dec 31, 2017
The Erdheim-Chester Disease Global Alliance adds four new ECD Care Centers in Canada and Europe.
Dec 31, 2017
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation.
